“…REL2 protein is predominantly expressed by the corpus luteum , and was extensively studied as a pregnancy hormone, with the levels exclusively measured by immunoassays. REL2 played a crucial role in preparing the birth canal for parturition , and was elevated in the first trimester , reaching its peak concentrations of 2.2 ng/mL. , Similar to alpha-fetoprotein, levels of REL2 in the subsequent second trimester decreased to 1–1.3 ng/mL. ,, Low levels of REL2 during pregnancy have been associated with recurrent miscarriage, toxemia of pregnancy, spontaneous abortion, ectopic pregnancy, and premature labor. − Those observations suggested that serum REL2 levels could serve as a potential marker of pregnancy complications, such as preeclampsia . In addition, REL2 has been suggested as a marker of ovarian cancer and a therapeutic target of ovarian cancer, fibrosis, and cardiovascular diseases. ,, Patients with serous adenocarcinoma had a median level of 78.1 pg/mL, a concentration well above the LOD of our IA-SRM assay (9.4 pg/mL).…”